Share on StockTwits

Deutsche Bank hoisted their price target on shares of Johnson & Johnson (NYSE:JNJ) from $52.00 to $53.00 in a research note issued on Tuesday. Deutsche Bank’s price target indicates a potential downside of 47.37% from the stock’s previous close.

JNJ has been the subject of a number of other recent research reports. Analysts at Zacks reiterated a “neutral” rating on shares of Johnson & Johnson in a research note on Thursday, May 8th. They now have a $106.00 price target on the stock. Separately, analysts at JPMorgan Chase & Co. reiterated a “neutral” rating on shares of Johnson & Johnson in a research note on Thursday, April 24th. They now have a $51.00 price target on the stock, down previously from $52.00. Finally, analysts at Argus raised their price target on shares of Johnson & Johnson from $104.00 to $116.00 in a research note on Thursday, April 17th. They now have a “buy” rating on the stock. One research analyst has rated the stock with a sell rating, six have issued a hold rating and seven have given a buy rating to the company. Johnson & Johnson has a consensus rating of “Hold” and an average price target of $82.25.

Shares of Johnson & Johnson (NYSE:JNJ) traded down 0.22% during mid-day trading on Tuesday, hitting $100.4136. 1,478,653 shares of the company’s stock traded hands. Johnson & Johnson has a 52-week low of $82.12 and a 52-week high of $101.98. The stock has a 50-day moving average of $99.52 and a 200-day moving average of $94.62. The company has a market cap of $284.1 billion and a price-to-earnings ratio of 19.25. Johnson & Johnson also saw unusually large options trading on Monday. Stock investors bought 13,652 call options on the stock. This is an increase of approximately 160% compared to the typical volume of 5,241 call options.

Johnson & Johnson (NYSE:JNJ) last posted its quarterly earnings results on Tuesday, April 15th. The company reported $1.54 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.48 by $0.06. The company had revenue of $18.10 billion for the quarter, compared to the consensus estimate of $18.00 billion. During the same quarter in the previous year, the company posted $1.44 earnings per share. The company’s revenue for the quarter was up 3.5% on a year-over-year basis. On average, analysts predict that Johnson & Johnson will post $5.88 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which is scheduled for Tuesday, June 10th. Stockholders of record on Tuesday, May 27th will be paid a dividend of $0.70 per share. This represents a $2.80 annualized dividend and a dividend yield of 2.78%. The ex-dividend date is Thursday, May 22nd. This is a boost from Johnson & Johnson’s previous quarterly dividend of $0.66.

Johnson & Johnson is a holding company. The Company is engaged in the research and development, manufacture and sale of a broad range of products in the health care field.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.